Favorable outcome in infants with AML after intensive first- and second-line treatment: an AML-BFM study group report
Open Access
- 4 October 2011
- journal article
- research article
- Published by Springer Science and Business Media LLC in Leukemia
- Vol. 26 (4), 654-661
- https://doi.org/10.1038/leu.2011.267
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- CNS irradiation in pediatric acute myleoid leukemia: Equal results by 12 or 18 Gy in studies AML‐BFM98 and 2004Pediatric Blood & Cancer, 2011
- Prognostic Impact of Specific Chromosomal Aberrations in a Large Group of Pediatric Patients With Acute Myeloid Leukemia Treated Uniformly According to Trial AML-BFM 98Journal of Clinical Oncology, 2010
- Infant acute lymphoblastic leukemia: Lessons learned and future directionsCurrent Hematologic Malignancy Reports, 2009
- Less Toxicity by Optimizing Chemotherapy, but Not by Addition of Granulocyte Colony-Stimulating Factor in Children and Adolescents With Acute Myeloid Leukemia: Results of AML-BFM 98Journal of Clinical Oncology, 2006
- Treatment strategies and long-term results in paediatric patients treated in four consecutive AML-BFM trialsLeukemia, 2005
- Allogeneic hematopoietic cell transplantation for infants with acute lymphoblastic leukemiaBlood, 2005
- Origins of chromosome translocations in childhood leukaemiaNature Reviews Cancer, 2003
- Effektive Rezidivtherapie der akuten myeloischen Leukämie im Kindesalter mit liposomalem Daunorubicin und CytarabinKlinische Padiatrie, 2002
- NONMEM population pharmacokinetic studies of cytosine arabinoside after high-dose and after loading bolus followed by continuous infusion of the drug in pediatric patients with leukemiasCancer Chemotherapy and Pharmacology, 1996
- Molecular rearrangements of the MLL gene are present in most cases of infant acute myeloid leukemia and are strongly correlated with monocytic or myelomonocytic phenotypes.JCI Insight, 1994